Clinical Outcomes after Treatment of Periodontal Intrabony Defects with Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial

類似資料

• Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects
  著者:: Esposito, Marco, 等
  出版事項: (2009)
• Comparative evaluation of the efficacy of synthetic nanocrystalline hydroxyapatite bone graft (Ostim(®)) and synthetic microcrystalline hydroxyapatite bone graft (Osteogen(®)) in the treatment of human periodontal intrabony defects: A clinical and denta scan study
  著者:: Kamboj, Monika, 等
  出版事項: (2016)
• Clinical and radiographic evaluation of nanocrystalline hydroxyapatite with or without platelet-rich fibrin membrane in the treatment of periodontal intrabony defects
  著者:: Elgendy, Enas Ahmed, 等
  出版事項: (2015)
• Comparison of nanocrystalline hydroxyapatite and synthetic resorbable hydroxyapatite graft in the treatment of intrabony defects: A clinical and radiographic study
  著者:: Bansal, Mansi, 等
  出版事項: (2014)
• Use of enamel matrix proteins for treatment of periodontal intrabony defects: A clinical and radiographic study
  著者:: Dinesh Hingorani, 等
  出版事項: (2009-01-01)